Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ascentage Pharma Announces Clinical Trial Agreement to Evaluate the Combination of Lisaftoclax (APG-2575) and the CDK4/6 Inhibitor IBRANCE® (Palbociclib) in Metastatic ER+/HER2- Breast Cancer 2021-11-08 21:47
Farmmi Announces Latest Multi-Product Sales Win 2021-11-08 21:00
Everest Medicines Announces Up to HK$100 million Additional Share Repurchase Program 2021-11-08 08:10
PromarkerD significantly outperforms current standard of care tests in predicting future kidney function decline 2021-11-05 20:37
Gracell Biotechnologies to Present Preclinical Results of TruUCAR-enabled CD19/CD7 Dual-Directed Allogeneic CAR-T Cell Therapy (GC502) for B-Cell Malignancies at the 63rd ASH Annual Meeting 2021-11-04 21:05
I-Mab to Present Clinical Data of Lemzoparlimab in Combination with Rituximab in Non-Hodgkins's Lymphoma at ASH 2021 2021-11-04 21:00
Taizhou, China: Building a Famous Chinese Medical City with Efforts 2021-11-04 20:16
Alterity Therapeutics Announces New Publications Providing Further Evidence of the Potential of ATH434 to Treat Neurodegenerative Diseases 2021-11-04 19:30
Gold Technology for Immune Response Cancer Therapy Licensed to OncoTEX 2021-11-03 22:00
Standigm Files PCT Patent Application of AI-driven Repurposed Drugs for Primary Mitochondrial Disease 2021-11-03 21:00
Vazyme to Reveal Its Latest COVID-19 Testing Products and Solutions at MEDICA 2021 2021-11-03 15:00
Chong Yoon Lim, CEO of Hanmi Science, announces addition of eWorldwide Group to Hanmi Science Consortium and invites other groups to join 2021-11-03 12:28
Daewoong's "Leaps and Bounds" Q3 Performance, Exceeds KRW 20B in Operating Income for Three Consecutive Quarters 2021-11-02 21:00
GenScript Expands Commercial Production in U.S. with State-of-the-Art Gene Synthesis Center 2021-11-02 19:30
New discovery: Banana beats insomnia and anti-anxiety, approved by the US FDA 2021-11-02 09:00
Invetech Named Victorian Top Exporter of the Year 2021-10-30 05:35
Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia 2021-10-29 19:15
Operating Income of Yiling Pharmaceutical in First 3 Quarters Reaches CNY 8.112 Billion, Up 25.81% 2021-10-29 17:17
Appendix 4C - Q1 FY22 Quarterly Cash Flow Report 2021-10-29 14:50
Aiming for Global CDMO, Xcell Therapeutics opens an export route to 62 countries with cell therapy culture technology. 2021-10-28 21:00
1 96 97 98 99 100 222